Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2023 update and perspectives.
Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, Kario K. Mogi M, et al. Among authors: tomitani n. Hypertens Res. 2024 Jan;47(1):6-32. doi: 10.1038/s41440-023-01398-5. Epub 2023 Sep 15. Hypertens Res. 2024. PMID: 37710033 Review.
Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S. Kario K, et al. Among authors: tomitani n. Circ J. 2017 Jun 23;81(7):948-957. doi: 10.1253/circj.CJ-17-0109. Epub 2017 Mar 17. Circ J. 2017. PMID: 28321001 Free article. Clinical Trial.
Comparison of ambulatory blood pressure-lowering effects of higher doses of different calcium antagonists in uncontrolled hypertension: the Calcium Antagonist Controlled-Release High-Dose Therapy in Uncontrolled Refractory Hypertensive Patients (CARILLON) Study.
Mizuno H, Hoshide S, Tomitani N, Kario K. Mizuno H, et al. Among authors: tomitani n. Blood Press. 2017 Oct;26(5):284-293. doi: 10.1080/08037051.2017.1329623. Epub 2017 May 19. Blood Press. 2017. PMID: 28524699 Clinical Trial.
Comparative effects of valsartan plus either cilnidipine or hydrochlorothiazide on home morning blood pressure surge evaluated by information and communication technology-based nocturnal home blood pressure monitoring.
Fujiwara T, Tomitani N, Kanegae H, Kario K. Fujiwara T, et al. Among authors: tomitani n. J Clin Hypertens (Greenwich). 2018 Jan;20(1):159-167. doi: 10.1111/jch.13154. Epub 2018 Jan 5. J Clin Hypertens (Greenwich). 2018. PMID: 29316213 Free PMC article. Clinical Trial.
Effect of canagliflozin on nocturnal home blood pressure in Japanese patients with type 2 diabetes mellitus: The SHIFT-J study.
Kario K, Hoshide S, Okawara Y, Tomitani N, Yamauchi K, Ohbayashi H, Itabashi N, Matsumoto Y, Kanegae H. Kario K, et al. Among authors: tomitani n. J Clin Hypertens (Greenwich). 2018 Oct;20(10):1527-1535. doi: 10.1111/jch.13367. Epub 2018 Sep 23. J Clin Hypertens (Greenwich). 2018. PMID: 30246286 Free PMC article. Clinical Trial.
68 results